These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8600226)

  • 1. Naltrexone treatment of self-injurious thoughts and behaviors.
    Sonne S; Rubey R; Brady K; Malcolm R; Morris T
    J Nerv Ment Dis; 1996 Mar; 184(3):192-5. PubMed ID: 8600226
    [No Abstract]   [Full Text] [Related]  

  • 2. Clonidine in acute aversive inner tension and self-injurious behavior in female patients with borderline personality disorder.
    Philipsen A; Richter H; Schmahl C; Peters J; Rüsch N; Bohus M; Lieb K
    J Clin Psychiatry; 2004 Oct; 65(10):1414-9. PubMed ID: 15491247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of dissociative symptoms in borderline personality disorder with naltrexone: supplementary comments].
    Schmahl C; Bohus M
    Nervenarzt; 2000 May; 71(5):427. PubMed ID: 10846724
    [No Abstract]   [Full Text] [Related]  

  • 4. Initial evidence of the beneficial effects of glutamate-modulating agents in the treatment of self-injurious behavior associated with borderline personality disorder.
    Pittenger C; Krystal JH; Coric V
    J Clin Psychiatry; 2005 Nov; 66(11):1492-3. PubMed ID: 16420092
    [No Abstract]   [Full Text] [Related]  

  • 5. Pain perception in self-injurious borderline patients: naloxone effects.
    Russ MJ; Roth SD; Kakuma T; Harrison K; Hull JW
    Biol Psychiatry; 1994 Feb; 35(3):207-9. PubMed ID: 8173022
    [No Abstract]   [Full Text] [Related]  

  • 6. [Naltrexone in the treatment of dissociative disorders--reflections with regard to a comprehensive therapeutic concept of borderline disorders].
    Bolm T; Piegler T
    Psychiatr Prax; 2001 Jul; 28(5):214-8. PubMed ID: 11479827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naltrexone for Self-Injury in Borderline Personality With Venlafaxine-Associated Hyponatremia.
    DeLucia B
    J Clin Psychopharmacol; 2017 Dec; 37(6):743-745. PubMed ID: 28891834
    [No Abstract]   [Full Text] [Related]  

  • 8. Naltrexone as a treatment for repetitive self-injurious behaviour:an open-label trial.
    Roth AS; Ostroff RB; Hoffman RE
    J Clin Psychiatry; 1996 Jun; 57(6):233-7. PubMed ID: 8666558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medically self-harming behavior and its relationship to borderline personality among psychiatric inpatients.
    Sansone RA; Songer DA; Gaither GA
    J Nerv Ment Dis; 2000 Jun; 188(6):384-6. PubMed ID: 10890349
    [No Abstract]   [Full Text] [Related]  

  • 10. Phenomenology of self-injury among inpatient women with borderline personality disorder.
    Shearer SL
    J Nerv Ment Dis; 1994 Sep; 182(9):524-6. PubMed ID: 8083682
    [No Abstract]   [Full Text] [Related]  

  • 11. Naltrexone as a treatment of self-injurious behavior--a case report.
    Griengl H; Sendera A; Dantendorfer K
    Acta Psychiatr Scand; 2001 Mar; 103(3):234-6. PubMed ID: 11240582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of naltrexone for dissociative symptoms in borderline personality disorder.
    Schmahl C; Kleindienst N; Limberger M; Ludäscher P; Mauchnik J; Deibler P; Brünen S; Hiemke C; Lieb K; Herpertz S; Reicherzer M; Berger M; Bohus M
    Int Clin Psychopharmacol; 2012 Jan; 27(1):61-8. PubMed ID: 22002175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-harm behaviors in borderline personality: an analysis by gender.
    Sansone RA; Lam C; Wiederman MW
    J Nerv Ment Dis; 2010 Dec; 198(12):914-5. PubMed ID: 21135645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cessation of self-mutilation in a patient with borderline personality disorder treated with naltrexone.
    McGee MD
    J Clin Psychiatry; 1997 Jan; 58(1):32-3. PubMed ID: 9055839
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical effects of naltrexone on autistic behavior.
    Zingarelli G; Ellman G; Hom A; Wymore M; Heidorn S; Chicz-DeMet A
    Am J Ment Retard; 1992 Jul; 97(1):57-63. PubMed ID: 1497864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naltrexone treatment for a 3-year-old boy with self-injurious behavior.
    White T; Schultz SK
    Am J Psychiatry; 2000 Oct; 157(10):1574-82. PubMed ID: 11007709
    [No Abstract]   [Full Text] [Related]  

  • 17. Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. Double-blind placebo-controlled studies.
    Willemsen-Swinkels SH; Buitelaar JK; Nijhof GJ; van England H
    Arch Gen Psychiatry; 1995 Sep; 52(9):766-73. PubMed ID: 7654128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naltrexone in autistic children: behavioral symptoms and attentional learning.
    Campbell M; Anderson LT; Small AM; Adams P; Gonzalez NM; Ernst M
    J Am Acad Child Adolesc Psychiatry; 1993 Nov; 32(6):1283-91. PubMed ID: 8282676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frontal white matter integrity in borderline personality disorder with self-injurious behavior.
    Grant JE; Correia S; Brennan-Krohn T; Malloy PF; Laidlaw DH; Schulz SC
    J Neuropsychiatry Clin Neurosci; 2007; 19(4):383-90. PubMed ID: 18070840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N of 1 randomized control trial for BPD patients.
    Links PS; Boiago I
    Can J Psychiatry; 1992 Mar; 37(2):148. PubMed ID: 1562961
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.